AnuBio
Anu Bio is a techbio startup focused on reimagining drug discovery using AI to develop immunotherapies and antibody-based drugs. Their proprietary AI architecture enables data-driven decision making throughout drug discovery and development, powering an internal engine that produces novel drug candidates against cancer. Their foundational AI model simulates cellular communication as a digital twin of the human immune system, supporting drug discovery, patient stratification, and clinical trial simulation. The company emphasizes lean and effective R&D with a team of interdisciplinary scientists and a culture of freedom with accountability, aiming to derisk drug development by predicting clinical performance of lead candidates.
AnuBio
Anu Bio is a techbio startup focused on reimagining drug discovery using AI to develop immunotherapies and antibody-based drugs. Their proprietary AI architecture enables data-driven decision making throughout drug discovery and development, powering an internal engine that produces novel drug candidates against cancer. Their foundational AI model simulates cellular communication as a digital twin of the human immune system, supporting drug discovery, patient stratification, and clinical trial simulation. The company emphasizes lean and effective R&D with a team of interdisciplinary scientists and a culture of freedom with accountability, aiming to derisk drug development by predicting clinical performance of lead candidates.